RecruitingNot ApplicableNCT04783103

Neuromodulation in the Elderly Depressed: a Brain Imaging Pilot Study

Neuromodulation in the Elderly Depressed: a Brain Im-aging Pilot Study


Sponsor

Universitair Ziekenhuis Brussel

Enrollment

44 participants

Start Date

May 7, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

To evaluate safety and efficacy of an accelerated deep brain Transcranial Magnetic stimulation (adTMS) and transcutaneous direct current stimulation (tDCS) protocol in an elderly depressed patient population


Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This brain imaging pilot study looks at how a type of brain stimulation — called TMS (transcranial magnetic stimulation) or another neuromodulation method — affects older adults (65+) with treatment-resistant depression. Brain scans before and after treatment will help researchers understand why some people respond better than others. **You may be eligible if...** - You are 65 or older, whether treated in a hospital or as an outpatient - You have been diagnosed with unipolar depression and have a moderately high depression score on a standard rating scale - You have tried at least one antidepressant medication that didn't fully work - You are willing to continue your current antidepressant at a stable dose during the study **You may NOT be eligible if...** - You have psychosis (other than depression-related) - You have a metal implant in your head or a pacemaker (which would make brain stimulation unsafe) - You have epilepsy or a seizure disorder - You are at high risk of suicide Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEa Magstim Rapid2 Plus1 Magnetic Stimulator connected to a Brainsway H1 coil

3 weeks home use


Locations(1)

UZ Brussel

Jette, Brussels Capital, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04783103


Related Trials